Considerations for the Care of Women with Gynecological Cancers during the COVID-19 Pandemic
Delivering care for patients with cancer during the COVID-19 pandemic can pose a significant challenge, given the fact that cancer patients face a higher risk of morbidity and mortality from the infection. Outcomes in gynecological cancers are heavily stage-dependent, ranging from 5-year survival 95...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2020-09-01
|
| Series: | Indian Journal of Cardiovascular Disease in Women |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1716924 |
| Summary: | Delivering care for patients with cancer during the COVID-19 pandemic can pose a significant challenge, given the fact that cancer patients face a higher risk of morbidity and mortality from the infection. Outcomes in gynecological cancers are heavily stage-dependent, ranging from 5-year survival 95% in early stage to less than 15% in advanced stages. Early diagnosis and timely treatment are therefore of the utmost importance, but they should be balanced, considering the availability of local expertise and resources and the local pandemic status. This article outlines the management guidelines for the care of women with gynecological malignancies during the COVID-19 pandemic. |
|---|---|
| ISSN: | 2455-7854 |